Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 702921, 5 pages
http://dx.doi.org/10.1155/2015/702921
Review Article

Somatostatin Analogs in the Medical Management of Occult Bleeding of the Lower Digestive Tract

1Department of Medicine, St. Michael’s Hospital, Dun Laoghaire, County Dublin, Ireland
2Department of General Internal Medicine, St. Columcille’s Hospital, Loughlinstown, County Dublin, Ireland

Received 31 October 2014; Accepted 3 March 2015

Academic Editor: Caroline Nordenvall

Copyright © 2015 Julie Martin-Grace and Gianluca Tamagno. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Gastroenterological Association, “American Gastroenterological Association medical position statement: evaluation and management of occult and obscure gastrointestinal bleeding,” Gastroenterology, vol. 118, no. 1, pp. 197–200, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. P. G. Foutch, “Angiodysplasia of the gastrointestinal tract,” The American Journal of Gastroenterology, vol. 88, no. 6, pp. 807–818, 1993. View at Google Scholar · View at Scopus
  3. J. J. Vargo, “Clinical applications of the argon plasma coagulator,” Gastrointestinal Endoscopy, vol. 59, no. 1, pp. 81–88, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. S. S. Sami, S. A. Al-Araji, and K. Ragunath, “Review article: gastrointestinal angiodysplasia—pathogenesis, diagnosis and management,” Alimentary Pharmacology and Therapeutics, vol. 39, no. 1, pp. 15–34, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Junquera, F. Feu, M. Papo et al., “A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia,” Gastroenterology, vol. 121, no. 5, pp. 1073–1079, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. B. S. Lewis, P. Salomon, S. Rivera-MacMurray, A. A. Kornbluth, J. Wenger, and J. D. Waye, “Does hormonal therapy have any benefit for bleeding angiodysplasia?” Journal of Clinical Gastroenterology, vol. 15, no. 2, pp. 99–103, 1992. View at Publisher · View at Google Scholar · View at Scopus
  7. Z.-Z. Ge, H.-M. Chen, Y.-J. Gao et al., “Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation,” Gastroenterology, vol. 141, no. 5, pp. 1629–1637, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Garrido, M. Sayago, J. López, R. León, F. Bellido, and J. L. Márquez, “Thalidomide in refractory bleeding due to gastrointestinal angiodysplasias,” Revista Española de Enfermedades Digestivas, vol. 104, no. 2, pp. 69–71, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Scarpignato and I. Pelosini, “Somatostatin for upper gastrointestinal hemorrhage and pancreatic surgery. A review of its pharmacology and safety,” Digestion, vol. 60, supplement 3, pp. 1–16, 1999. View at Google Scholar · View at Scopus
  10. A. K. Kubba, H. Dallai, G. H. Haydon, P. C. Hayes, and K. R. Palmer, “The effect of octreotide on gastroduodenal blood flow measured by laser Doppler flowmetry in rabbits and man,” The American Journal of Gastroenterology, vol. 94, no. 4, pp. 1077–1082, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Barrie, E. A. Woltering, H. Hajarizadeh, C. Mueller, T. Ure, and W. S. Fletcher, “Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent,” Journal of Surgical Research, vol. 55, no. 4, pp. 446–453, 1993. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Tulassay, “Somatostatin and the gastrointestinal tract,” Scandinavian Journal of Gastroenterology, vol. 33, no. 228, pp. 115–121, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Scaglione, L. Pietrini, F. Russo, M. R. Franco, and I. Sorrentini, “Long-acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angiodysplasia,” Alimentary Pharmacology & Therapeutics, vol. 26, no. 6, pp. 935–942, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. A. K. Burroughs and R. Malagelada, “Potential indications for octreotide in gastroenterology: summary of workshop,” Digestion, vol. 54, supplement 1, pp. 59–67, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. F. P. Rossini, A. Arrigoni, and M. Pennazio, “Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine,” American Journal of Gastroenterology, vol. 88, no. 9, pp. 1424–1427, 1993. View at Google Scholar · View at Scopus
  16. G. Nardone, A. Rocco, T. Balzano, and G. Budillon, “The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract,” Alimentary Pharmacology & Therapeutics, vol. 13, no. 11, pp. 1429–1436, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Orsi, C. Guatti-Zuliani, and L. Okolicsanyi, “Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract,” Digestive and Liver Disease, vol. 33, no. 4, pp. 330–334, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Tamagno, R. Mioni, E. de Carlo, P. Maffei, D. Rubello, and N. Sicolo, “Effects of a somatostatin analogue in occult gastrointestinal bleeding: a case report,” Digestive and Liver Disease, vol. 36, no. 12, pp. 843–846, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Junquera, E. Saperas, S. Videla et al., “Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia,” The American Journal of Gastroenterology, vol. 102, no. 2, pp. 254–260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Brown, V. Subramanian, C. Mel Wilcox, and S. Peter, “Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: an overview and systematic review of prospective observational studies,” Digestive Diseases and Sciences, vol. 55, no. 8, pp. 2129–2134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Bon, T. Aparicio, M. Vincent et al., “Long-acting somatostatin analogues decrease blood transfusion requirements in patients with refractory gastrointestinal bleeding associated with angiodysplasia,” Alimentary Pharmacology and Therapeutics, vol. 36, no. 6, pp. 587–593, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Salgueiro, R. Marcos-Pinto, R. Liberal et al., “Octreotide long-acting release is effective in preventing gastrointestinal bleeding due to angiodysplasias,” GE Portuguese Journal of Gastroenterology, vol. 21, no. 5, pp. 176–183, 2014. View at Publisher · View at Google Scholar
  23. G. Nardone, D. Compare, C. Scarpignato, and A. Rocco, “Long acting release-octreotide as ‘rescue’ therapy to control angiodysplasia bleeding: a retrospective study of 98 cases,” Digestive and Liver Disease, vol. 46, pp. 688–694, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Bowers, O. McNulty, and E. Mayne, “Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease,” British Journal of Haematology, vol. 108, no. 3, pp. 524–527, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Blich, O. Fruchter, S. Edelstein, and Y. Edoute, “Somatostatin therapy ameliorates chronic and refractory gastrointestinal bleeding caused by diffuse angiodysplasia in a patient on anticoagulation therapy,” Scandinavian Journal of Gastroenterology, vol. 38, no. 7, pp. 801–803, 2003. View at Publisher · View at Google Scholar · View at Scopus